Gilead Sciences officer proposes $514K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gilead Sciences, Inc. (GILD) officer Andrew Dickinson gave notice of a proposed sale of 3,000 common shares, with an aggregate market value of $514,410 and an approximate sale date of November 16, 2026. Morgan Stanley Smith Barney LLC is named as broker. The stated Rule 10b5-1 plan adoption or instruction date is August 29, 2024. Dickinson acquired 3,000 performance shares from Gilead on January 31, 2024.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent GILD stock sales did Andrew Dickinson report?
AI-generated analysis. How Rhea-AI works. Not financial advice.